Shares of Danish pharmaceutical giant Novo Nordisk plummeted more than 22% on Friday after reporting results in a late-stage trial that missed expectations.
Related Posts
Trump to impose 25% tariffs on steel and aluminum — here are the likely winners and losers
Perhaps unsurprisingly, the biggest winner of the trade tariffs is likely to be the U.S.
Russians accused of crimes offered choice – go to war instead of court
A former Olympic athlete has been told if he fights in Ukraine a criminal case against him will be frozen.
Two Russian oil tankers wrecked in Black Sea
Video appears to show one of the tankers broken in half and sinking amid a heavy storm, with oil visible…